Virpax Pharmaceuticals
Manufacturing · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1055 Westlakes Dr Ste 300, Berwyn, Penns...Phone Number
(610) 727-4597Website
www.virpaxpharma.comRevenue
<$5 MillionStock Symbol
VRPXIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Virpax Pharmaceuticals
Virpax is developing branded product candidates for non-addictive pain management and neurological disorders using its proprietary technologies to optimize and target drug delivery. Virpax is initially seeking FDA approval of its three patented drug delivery platforms. Epoladerm is a topical diclofenac spray film formulation being developed to manage osteoarthritis pain. Probudur is a single injection long-acting liposomal bupivacaine formulation being developed to manage post-operative pain. Envelta is an intranasal Molecular-Envelope Technology (MET) enkephalin formulation being developed for the management post cancer pain and non-cancer pain, as well as post-traumatic stress disorder (PTSD) under the name PES200. MET technology is also used in AnQlar, a candidate to inhibit viral replication caused by influenza or SARS-CoV-2. Virpax recently acquired global rights to VRP324, a product candidate for the nasal delivery of a pharmaceutical-grade cannabidiol (CBD) for the management ofRead more
Virpax Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Virpax Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Virpax Pharmaceuticals recently announced quarterly report
Check out if Virpax Pharmaceuticals is spiking on competitors!
Product Launch: Get notified when Virpax Pharmaceuticals launches new products
Check if Virpax Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Virpax Pharmaceuticals
Website visits: Recent activity has been detected on your website
Virpax Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Virpax Pharmaceuticals had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Virpax Pharmaceuticals has new funding data
Recommended Actions
Find VP level buyers at Virpax Pharmaceuticals
Find 3 more new buyers
Compare Similar Companies to Virpax Pharmaceuticals
Compare insights from companies similar to Virpax Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Virpax Pharmaceuticals
<$5M
1-10
Public
-
2017
Jatinder DhaliwalCEO & Interim Chief Financial Officer & Director
Company Profile Activity
Activity Insights
Virpax Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Virpax Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Virpax Pharmaceuticals.
Virpax Pharmaceuticals Tech Stack
A closer look at the technologies used by Virpax Pharmaceuticals
See more technologies
Most Recent Scoops
Executive Move
Executive Moves, Board of Directors
Left Company
Executive Move
Executive Moves, Left Company
Executive Move
Executive Moves, Board of Directors
Executive Move
Executive Moves, Board of Directors
Left Company
Executive Move
Executive Moves, Left Company
Virpax Pharmaceuticals News & Media
Virpax Looking to Use MET to Develop Intranasal COVID Vaccine
BERWYN, Pa.--(BUSINESS WIRE)--Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indications, is looking to use Molecular Envelope Technology (MET) or a similar technology to deliver a mRNA COVID vaccine. Virpax currently uses its MET for Envelta (NES100) and NobrXiol (VRP324). The Company will look tVirpax’s NES100 to be Presented at The Society of Toxicology by NCATS
BERWYN, Pa.--(BUSINESS WIRE)--Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indications, is pleased to announce its NES100 dose range finding toxicity study will be presented at The Society of Toxicology (SOT) 64th annual meeting and Tox Expo taking place March 16-20th in Orlando, FL. This is a pVirpax Reports Positive Results in Human Study for its Molecular Envelope Technology
BERWYN, Pa.--(BUSINESS WIRE)--Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indications, would like to congratulate Nanomerics on completing a human study using the Molecular Envelope Technology (MET) and showing no moderate to severe adverse events. Virpax uses MET in its Envelta (NES100) and NoVirpax Confirms Positive Results with US Army with Probudur™ for Combat Care Study
BERWYN, Pa.--(BUSINESS WIRE)--Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indications, today announced the completion of the full study that followed the initial Probudur™ pilot study performed by the U.S. Army Institute of Surgical Research (USAISR) under an existing Cooperative Research and D
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Virpax Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Virpax is developing branded product candidates for non-addictive pain management and neurological disorders using its proprietary technologies to optimize and target drug delivery. Virpax is initially seeking FDA approval of its three patented drug delivery platforms. Epoladerm is a topical diclofenac spray film formulation being developed to mana... Read More
